sepsis
The company's test uses qPCR to measure the expression of two genes to determine the probability of sepsis.
Selux Diagnostics Next Generation Phenotyping System Gets FDA 510(k) Clearance
The firm's rapid testing system was cleared along with a Gram-positive bacteria panel determining susceptibility to 14 antimicrobials.
The firm is developing a shoebox-size gas chromatography instrument that could be used for routine screenings and critical illness detection and monitoring.
Aided by COVID-19 Funding, Firms Continued Developing Handheld Diagnostic Instruments in 2022
Premium
The lightweight, portable instruments coming onto the market employ promise to deliver test results closer to patients, potentially hastening treatments.
DeepUll Inks €20M Loan Agreement With European Investment Bank
The loan will finance DeepUll's research, development, and innovation efforts for its culture-free diagnostics platform for the early identification of sepsis.
Nov 7, 2022
Cepheid Nabs CE Mark for Group B Strep Test
Oct 28, 2022
Oct 20, 2022
Sepsis Testing Startup DeepUll Raises €13M
Sep 28, 2022
Aug 15, 2022